Capstone Investment Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,980
Closed -$438K 1924
2025
Q3
$438K Buy
40,980
+17,816
+77% +$175K ﹤0.01% 1469
2025
Q2
$224K Buy
+23,164
New +$239K ﹤0.01% 1498
2024
Q3
Sell
-16,180
Closed -$335K 2114
2024
Q2
$335K Buy
16,180
+7,818
+93% +$155K ﹤0.01% 1531
2024
Q1
$157K Sell
8,362
-17,018
-67% -$292K ﹤0.01% 2063
2023
Q4
$366K Sell
25,380
-9,177
-27% -$125K ﹤0.01% 1500
2023
Q3
$600K Buy
34,557
+21,330
+161% +$445K ﹤0.01% 1224
2023
Q2
$275K Buy
13,227
+4,427
+50% +$96.2K ﹤0.01% 1436
2023
Q1
$207K Buy
8,800
+2,764
+46% +$74.2K ﹤0.01% 1262
2022
Q4
$169K Sell
6,036
-2,519
-29% -$64.4K ﹤0.01% 1331
2022
Q3
$200K Buy
+8,555
New +$258K ﹤0.01% 1466
2022
Q2
Sell
-4,190
Closed -$147K 2029
2022
Q1
$146K Buy
+4,190
New +$143K ﹤0.01% 1811
2021
Q4
Sell
-758
Closed -$24.7K 2023
2021
Q3
$25K Buy
+758
New +$24.3K ﹤0.01% 1892

Other funds holding OGN

Capstone Investment Advisors's OGN Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 40,980 shares — an estimated $438K sold.

Capstone Investment Advisors first reported a position in OGN in Q3 2021 and held it in 12 quarters. The position peaked at $600K in Q3 2023. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 40,980 Organon & Co shares in Q4 2025, an estimated $438K.
  • Capstone Investment Advisors first reported a position in Organon & Co in Q3 2021 and held it in 12 quarters.
  • Capstone Investment Advisors's Organon & Co position peaked at $600K in Q3 2023.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.